These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. Intrinsic Antimicrobial Resistance Determinants in the Superbug Pseudomonas aeruginosa. Murray JL; Kwon T; Marcotte EM; Whiteley M mBio; 2015 Oct; 6(6):e01603-15. PubMed ID: 26507235 [TBL] [Abstract][Full Text] [Related]
71. High potency of sequential therapy with only β-lactam antibiotics. Batra A; Roemhild R; Rousseau E; Franzenburg S; Niemann S; Schulenburg H Elife; 2021 Jul; 10():. PubMed ID: 34318749 [TBL] [Abstract][Full Text] [Related]
72. Influence of ertapenem administration on the incidence of carbapenem-resistant Pseudomonas aeruginosa. Lima AL; Oliveira PR; Paula AP; Zumiotti AV Braz J Infect Dis; 2008 Apr; 12(2):105-6. PubMed ID: 18641844 [No Abstract] [Full Text] [Related]
79. Slt, MltD, and MltG of Pseudomonas aeruginosa as Targets of Bulgecin A in Potentiation of β-Lactam Antibiotics. Dik DA; Madukoma CS; Tomoshige S; Kim C; Lastochkin E; Boggess WC; Fisher JF; Shrout JD; Mobashery S ACS Chem Biol; 2019 Feb; 14(2):296-303. PubMed ID: 30620575 [TBL] [Abstract][Full Text] [Related]
80. Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Dötsch A; Becker T; Pommerenke C; Magnowska Z; Jänsch L; Häussler S Antimicrob Agents Chemother; 2009 Jun; 53(6):2522-31. PubMed ID: 19332674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]